- Home
- MANU vs ARWR Comparison
MANU vs ARWR Comparison
Compare MANU & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANU
- ARWR
- Stock Information
- Founded
- MANU 1878
- ARWR 2003
- Country
- MANU United Kingdom
- ARWR United States
- Employees
- MANU N/A
- ARWR N/A
- Industry
- MANU Services-Misc. Amusement & Recreation
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- MANU Consumer Discretionary
- ARWR Health Care
- Exchange
- MANU Nasdaq
- ARWR Nasdaq
- Market Cap
- MANU 2.2B
- ARWR 1.8B
- IPO Year
- MANU 2012
- ARWR 1993
- Fundamental
- Price
- MANU $14.31
- ARWR $13.03
- Analyst Decision
- MANU Buy
- ARWR Buy
- Analyst Count
- MANU 2
- ARWR 11
- Target Price
- MANU $20.75
- ARWR $41.44
- AVG Volume (30 Days)
- MANU 164.0K
- ARWR 1.6M
- Earning Date
- MANU 02-19-2025
- ARWR 05-12-2025
- Dividend Yield
- MANU N/A
- ARWR N/A
- EPS Growth
- MANU N/A
- ARWR N/A
- EPS
- MANU N/A
- ARWR N/A
- Revenue
- MANU $777,029,683.00
- ARWR $2,500,000.00
- Revenue This Year
- MANU $2.44
- ARWR $4,380.43
- Revenue Next Year
- MANU $3.82
- ARWR $64.24
- P/E Ratio
- MANU N/A
- ARWR N/A
- Revenue Growth
- MANU N/A
- ARWR N/A
- 52 Week Low
- MANU $12.05
- ARWR $9.57
- 52 Week High
- MANU $18.42
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- MANU 59.90
- ARWR 47.38
- Support Level
- MANU $14.17
- ARWR $12.44
- Resistance Level
- MANU $14.60
- ARWR $14.97
- Average True Range (ATR)
- MANU 0.32
- ARWR 0.74
- MACD
- MANU 0.06
- ARWR 0.11
- Stochastic Oscillator
- MANU 71.29
- ARWR 37.01
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.